|
NAA15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.060660E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.009000E-04 |
| Normal-vs-Stage2 |
1.794200E-02 |
| Normal-vs-Stage3 |
1.391360E-01 |
| Normal-vs-Stage4 |
1.757820E-01 |
| Stage1-vs-Stage2 |
7.449400E-01 |
| Stage1-vs-Stage3 |
6.579500E-02 |
| Stage1-vs-Stage4 |
1.002200E-01 |
| Stage2-vs-Stage3 |
1.458030E-01 |
| Stage2-vs-Stage4 |
1.874040E-01 |
| Stage3-vs-Stage4 |
9.920800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.779400E-04 |
| Normal-vs-AfricanAmerican |
5.484400E-01 |
| Normal-vs-Asian |
2.686800E-01 |
| Caucasian-vs-AfricanAmerican |
1.710170E-02 |
| Caucasian-vs-Asian |
9.024600E-01 |
| AfricanAmerican-vs-Asian |
4.359000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.546200E-02 |
| Normal-vs-Female |
4.36260000002964E-06 |
| Male-vs-Female |
6.605500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.788600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.400430E-03 |
| Normal-vs-Age(61-80Yrs) |
2.877800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.009400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.468200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.514000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.109400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.497400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.082200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.049600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.311700E-02 |
| Normal-vs-Grade 2 |
4.00990000000156E-05 |
| Normal-vs-Grade 3 |
5.649500E-02 |
| Normal-vs-Grade 4 |
6.553800E-01 |
| Grade 1-vs-Grade 2 |
4.593200E-01 |
| Grade 1-vs-Grade 3 |
2.789800E-02 |
| Grade 1-vs-Grade 4 |
1.118140E-02 |
| Grade 2-vs-Grade 3 |
4.322000E-03 |
| Grade 2-vs-Grade 4 |
1.019000E-03 |
| Grade 3-vs-Grade 4 |
2.322600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.29760000417068E-08 |
| Normal-vs-ccB subtype |
1.993220E-01 |
| ccA subtype-vs-ccB subtype |
2.50649999999908E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.776000E-04 |
| Normal-vs-N1 |
2.277200E-01 |
| N0-vs-N1 |
9.645400E-01 |
|
|
